Biosplice Therapeutics
Restore health by delivering first-in-class therapies that harness alternative splicing
San Diego, United States
37 employees
Grant
Total: $778.00M
Biotechnology, Health Care +1
General Information
Get notified when Biosplice Therapeutics moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Biosplice Therapeutics
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About Biosplice Therapeutics
Taxonomy: Medical Research, Therapeutics Development, Regenerative Medicine, Oncology, Degenerative Diseases, Alternative Splicing, Wnt Pathway Modulation, Small Molecule Therapeutics, Clinical Development, Tissue-Level Regeneration, Alzheimer's Disease, Pre-mRNA Splicing, CLK/DYRK Kinases, Regenerative Pathways
Services & Products
Target Customers
Funding Rounds & Investors (6)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | •••••• | 1 | •••• •••• | 08 Mar 2024 |
| Venture Round | •••••• | 5 |
|
15 Apr 2021 |
| Series C | •••••• | 1 | •••• •••• | 01 Apr 2019 |
| Series B | •••••• | 3 |
|
06 Aug 2018 |
| Series A | •••••• | 3 |
|
01 Sep 2013 |
Biosplice Therapeutics Alternatives & Competitors
Developing novel mRNA-based therapeutics
Reimagine the Power of RNA
Harnessing nature to program targeted, potent and tunable medicines
FAQ About Biosplice Therapeutics
Don't just browse. Track.
Signal Tracker monitors Biosplice Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
